To identify whether CCDC88A contributes to promote malignancies in HCC via regulating VEGFA, we added SKLB1002, a VEGFR2 inhibitor, with or without CCDC88A knockdown in Huh-7 and SK-HEP-1 followed by detecting malignancies. Here, KDR is linked to hepatocellular carcinoma.